Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Compass Therapeutics Q3 Earnings

Compass Therapeutics (NASDAQ:CMPX) reported its Q3 earnings results on Thursday, November 9, 2023 at 07:30 AM. Here’s what…
byBenzinga Insights
November 9, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Compass Therapeutics (NASDAQ:CMPX) reported its Q3 earnings results on Thursday, November 9, 2023 at 07:30 AM.

Here’s what investors need to know about the announcement.

Earnings

Compass Therapeutics beat estimated earnings by 27.27%, reporting an EPS of $-0.08 versus an estimate of $-0.11.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 5.26% drop in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Compass Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Recap: McGrath RentCorp Q2 Earnings

By Benzinga Insights
July 28, 5:59 PM
McGrath RentCorp (NASDAQ:MGRC) reported its Q2 earnings results on Thursday, July 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings McGrath RentCorp beat estimated earnings by 20.22%, reporting an EPS of $1.07 versus an estimate of $0.89.

MGRC